Anti-Toxoplasma gondii antibodies in patients with chronic heart failure

References

1. Altintas N., Yolasigmaz A., Yazar S., Sakru N., Kitapcioglu G. 1998; Investigation of Toxoplasma antibodies in residence of central Izmir and surrounding rural area. Act Parasitol Tur 22:229–232
   [Google Scholar]
2. Baumgarten G., Knuefermann P., Mann D. L. 2000; Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc Med 10:216–223 [CrossRef]
   [Google Scholar]
3. Beaver P. C., Jung R. C., Cupp E. W. 1984 Clinical Parasitology , 9th edn. Philadelphia: Lea & Febiger;
   [Google Scholar]
4. Campbell K. S., Colonna M. 2001; Human natural killer cell receptors and signal transduction. Int Rev Immunol 20:333–370 [CrossRef]
   [Google Scholar]
5. Daffos F., Forestier F., Capella-Pavlovsky M., Thulliez P., Aufrant C., Valenti D., Cox W. L. 1988; Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318:271–275 [CrossRef]
   [Google Scholar]
6. Denkers E. Y., Gazzinelli R. T. 1998; Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11:569–588
   [Google Scholar]
7. Deswal A., Petersen N. J., Feldman A. M., Young J. B., White B. G., Mann D. L. 2001; Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial (VEST). Circulation 103:2055–2059 [CrossRef]
   [Google Scholar]
8. Dubey J. P., Beattie C. P. 1988 Toxoplasmosis of Animals and Man Boca Raton, FL: CRC Press;
   [Google Scholar]
9. Feldman H. 1982; Epidemiology of Toxoplasma infections. Epidemiol Rev 4:204–213
   [Google Scholar]
10. Ferreira M. S., Borges A. S. 2002; Some aspects of protozoan infections in immunocompromised patients: a review. Mem Inst Oswaldo Cruz 97:443–457 [CrossRef]
    [Google Scholar]
11. Fuccillo E. A., Madden E. E., Tzan N., Sever J. L. 1987; Difficulties associated with serological diagnosis of Toxoplasma gondii infections. Diagn Clin Immunol 5:8–13
    [Google Scholar]
12. Garcia S. L., Bruckner A. D. 1997a; Tissue protozoa ( Toxoplasma gondii . In Diagnostic Medical Parasitology pp  111–121 Edited by Garcia S. L., Bruckner A. D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
13. Garcia S. L., Bruckner A. D. 1997b; Parasitic infections in the compromised host ( Toxoplasma gondii . In Diagnostic Medical Parasitology pp  423–424 Edited by Garcia S. L., Bruckner A. D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
14. Gazzinelli R. T., Wysocka M., Hayashi S., Denkers E. Y., Hieny S., Caspar P., Trinchieri G., Sher A. 1994; Parasite-induced IL-12 stimulates early IFN- γ synthesis and resistance during acute infection with Toxoplasma gondii . J Immunol 153:2533–2543
    [Google Scholar]
15. Kagi D., Ledermann B., Burki K., Zinkernagel R. M., Hengartner H. 1996; Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo . Annu Rev Immunol 14:207–232 [CrossRef]
    [Google Scholar]
16. Kos F. J. 1998; Regulation of adaptive immunity by natural killer cells. Immunol Res 17:303–312 [CrossRef]
    [Google Scholar]
17. Luft B. J., Remington J. S. 1988; Toxoplasmosis encephalitis. J Infect Dis 157:1–6 [CrossRef]
    [Google Scholar]
18. Montoya J. G., Remington J. S. 2000; Toxoplasma gondii . In Principles and Practice of Infectious Diseases pp  2858–2888 Edited by Mandell G. L., Bennett J. E., Dolin R. Philadelphia: Churchill Livingstone;
    [Google Scholar]
19. Mordue D. G., Monroy F., La Regina M., Dinarello C. A., Sibley L. D. 2001; Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 167:4574–4584 [CrossRef]
    [Google Scholar]
20. Moretta L., Bottina C., Pende D., Mingari M. C., Biassoni R., Moretta A. 2002; Human natural killer cells: their origin, receptors and function. Eur J Immunol 32:1205–1211 [CrossRef]
    [Google Scholar]
21. Navia B. A., Petito C. K., Gold J. W. M., Cho E. S., Jordon B. D., Price J. W. 1986; Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 19:224–238 [CrossRef]
    [Google Scholar]
22. Neyer L. E., Grunig G., Fort M., Remington J. S., Rennick D., Hunter C. A. 1997; Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii . Infect Immun 65:1675–1682
    [Google Scholar]
23. Satoskar A. R., Stamm L. M., Zhang X., Okano M., David J. R., Terhorst C., Wang B. 1999; NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response. J Immunol 163:5298–5302
    [Google Scholar]
24. Scharton-Kersten T. M., Wynn T. A., Denkers E. Y., Bala S., Showe L., Grunvald E., Hieny S., Gazzinelli R. T., Sher A. 1996; In the absence of endogenous IFN- γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 157:4045–4054
    [Google Scholar]
25. Vredevoe D. L., Moser D. K., Gan X. H., Bonavida B. 1995; Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine. Neuroimmunomodulation 2:16–24 [CrossRef]
    [Google Scholar]
26. Yazar S., Karagoz S., Altunoluk B., Kilic H. 2000; Investigation of anti- Toxoplasma gondii antibodies in patients suspected of toxoplasmosis. Act Parasitol Tur 24:14–16
    [Google Scholar]